George Jean 4
4 · ACCELERON PHARMA INC · Filed Jun 28, 2019
Insider Transaction Report
Form 4
George Jean
Director
Transactions
- Sale
Common Stock
2019-06-26$39.16/sh−25,688$1,005,942→ 15,562 total - Other
Common Stock
2019-06-26−11,812→ 3,750 total - Exercise/Conversion
Option to Purchase Common Stock
2019-06-26−20,000→ 0 totalExercise: $24.11Exp: 2023-12-05→ Common Stock (20,000 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2019-06-26−10,000→ 0 totalExercise: $27.97Exp: 2026-03-03→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2019-06-26$30.17/sh+7,500$226,275→ 41,250 total - Exercise/Conversion
Common Stock
2019-06-26$24.11/sh+20,000$482,200→ 23,750 total - Exercise/Conversion
Common Stock
2019-06-26$27.97/sh+10,000$279,700→ 33,750 total - Other
Common Stock
2019-06-26+11,812→ 11,812 total(indirect: See Footnote) - Sale
Common Stock
2019-06-28$41.17/sh−11,812$486,300→ 0 total(indirect: See Footnote) - Exercise/Conversion
Option to Purchase Common Stock
2019-06-26−7,500→ 0 totalExercise: $30.17Exp: 2027-03-02→ Common Stock (7,500 underlying)
Footnotes (7)
- [F1]These shares were sold to cover the exercise price of the three options reported herein.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) and (5) to this Form 4.
- [F3]The Reporting Person held the options and underlying shares for the benefit of ATV Capital Management, Inc. ("ACM") pursuant to ACM's policy with respect to equity compensation in respect of director service. Pursuant to the policy, the Reporting Person assigned these shares to ACM for no additional consideration.
- [F4]These securities are directly owned by ACM. The Reporting Person is a director of ACM. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of her pecuniary interest therein.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 40.93 to 41.37, inclusive.
- [F6]The shares of common stock underlying this stock option award vested in equal quarterly installments over the first three years after the grant.
- [F7]The shares of common stock underlying this stock option award vested in full on the one year anniversary of the grant date.